Evidence map›Paper›PMID 40932673›Full record

ArticleJournal of medical systems2025

Prediction Model of Intradialytic Hypertension in Hemodialysis Patients Based on Machine Learning.

Yu Wang, Hongming Zhou, Qi Guo, Kang Wang, Yehua Luo, Shaodong Luan, Donge Tang, Shuangyong Dong, Lianghong Yin, Yong Dai

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu Wang *Department of Emergency, School of Medicine, Hangzhou Geriatric Hospital, Affiliated Hangzhou First People's Hospital Chengbei Campus, Westlake University, Hangzhou, 310005, China.
Hongming Zhou *Departments of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen, 518020, China.
Qi Guo *College of Semiconductors (National Graduate College for Engineers), Southern University of Science and Technology, Shenzhen, 518055, China.
Kang WangDepartment of Nephrology, Shenzhen People's Hospital, the Second Affiliated Hospital of Jinan University, Jinan University, Shenzhen, 518020, China.
Yehua LuoDepartment of Nephrology, Fuding Hospital, Fujian University of Traditional Chinese Medicine, Fuding, 355200, China.
Shaodong LuanDepartments of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen, 518020, China.
Donge TangClinical Medical Research Center, Shenzhen People's Hospital, the Second Clinical Medical College of Jinan University, Jinan University, Shenzhen, 518020, China.
Shuangyong DongDepartment of Emergency, School of Medicine, Hangzhou Geriatric Hospital, Affiliated Hangzhou First People's Hospital Chengbei Campus, Westlake University, Hangzhou, 310005, China. dsy771015@126.com.
Lianghong YinInstitute of Nephrology and Blood Purification, the First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, 510632, China. yin-yun@126.com.
Yong DaiGuangdong Provincial Autoimmune Disease Precision Medicine Engineering Research Center, Shenzhen Autoimmune Disease Engineering Research Center, Shenzhen Geriatrics Clinical Research Center, Shenzhen People 's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, 518020, China. daiyong@mail.sustech.edu.cn.

Funding

Guangdong Engineering Technology Research Center 507204531040Guangdong Provincial R&D Program for Key Areas Grant No. 2023 B0101200010Guangzhou Development Zone entrepreneurship leading talent project 2017-L153Shenzhen Longhua District Science and technology innovation special fund project 11501A20220923BE5B6B3;11501A20220923BD5F291
6 · The paper itself

Abstract

The escalating global burden of chronic kidney disease (CKD), particularly end-stage renal disease (ESRD), has intensified reliance on hemodialysis (HD), imposing substantial financial and operational burdens on healthcare systems and patients. Intradialytic hypertension (IDH), a critical complication during HD, is associated with life-threatening cardiovascular and neurological sequelae if unmanaged. This study aims to develop a machine learning (ML)-driven early-alert system for IDH risk prediction by integrating demographic profiles and dialysis session records, enabling clinicians to preemptively identify high-risk patients and prioritize targeted monitoring. Two clinical prediction models (IDH-1 and IDH-2) were developed using Light Gradient Boosting Machine (LGBM), Support Vector Machine (SVM), and TabNet algorithms. IDH-1 estimates immediate hypertension risk by analyzing pre-dialysis vital signs and longitudinal treatment patterns, whereas IDH-2 predicts subsequent session risks by synthesizing real-time dialysis parameters with historical biomarkers. Model performance was rigorously validated using standardized metrics, including AUC-ROC, sensitivity, accuracy, and F1 score, to ensure clinical applicability. 185,125 HD sessions as training set and 71,427 sessions as testing set were used in this study. For IDH-1, the LGBM model demonstrated superior discriminative capacity (AUC: 0.87; recall: 0.73; F1 score: 0.36), outperforming SVM and TabNet. Similarly, LGBM achieved the highest performance for IDH-2 (AUC: 0.74; recall: 0.56; F1 score: 0.26). Most significant parameters in IDH-1 Predictor with LGBM were pre-dialysis diastolic pressures, historical mean arterial pressure, and historical average IDH episodes. For the IDH-2 model with LGBM, historical average IDH episodes and post-dialysis systolic pressures were most important parameters. This study provides two kinds of superior discriminative capacity LGBM model for IDH predicting. The proposed models offer a scalable framework for personalized risk stratification, potentially mitigating adverse outcomes in hemodialysis populations.

Indexed as

HypertensionKidney Failure, ChronicMachine LearningRenal DialysisAdultAgedAlgorithmsFemaleHumansMaleMiddle AgedRisk AssessmentSupport Vector MachineEnd-stage renal diseaseHemodialysisLight gradient boosting machineMachine learning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.